Pharming Group N.V.
PHGUF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,004 | $788 | $602 | $668 |
| - Cash | $113 | $92 | $60 | $55 |
| + Debt | $112 | $128 | $119 | $112 |
| Enterprise Value | $1,002 | $824 | $661 | $725 |
| Revenue | $97 | $93 | $79 | $93 |
| % Growth | 4.4% | 17.9% | -14.7% | – |
| Gross Profit | $90 | $84 | $71 | $80 |
| % Margin | 92.7% | 90.4% | 89.5% | 86.8% |
| EBITDA | $23 | $10 | -$4 | $16 |
| % Margin | 24.1% | 10.5% | -5.2% | 16.9% |
| Net Income | $8 | $5 | -$15 | $4 |
| % Margin | 7.8% | 5% | -18.6% | 3.9% |
| EPS Diluted | 0.011 | 0.007 | -0.022 | 0.005 |
| % Growth | 61.4% | 131.8% | -540% | – |
| Operating Cash Flow | $30 | $12 | $0 | $9 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $30 | $12 | -$0 | $9 |